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Marine actinomycetes have great potential as producers of unique bioactive compounds due to its 
special adaptation in the harsh environment in the oc an. In this study, 100 strains of actinomycetes w re 
isolated from marine sponges collected from sea are close to Sipadan Island in Sabah. Each strain was 
fermented in mannitol-peptone broth and the secondary metabolites were extracted by using acetone. The 
secondary metabolites were tested for their antimicrob al and antioxidant activity. The data showed that 22 
strains exhibited potent antioxidant activity (IC50 between 56.3 and 99.1 µg/ml) in DPPH assay and 31 strain  
have strong inhibition activity (8 mm to 19 mm)  on test pathogens (Bacillus cereus, Bacillus subtilis, 
Staphylococcus aureus, Streptococcus pyogenes, Escherichia coli, Klebsiella spp., Streptococcus pneumonia 
and Pseudomonas aeruginosa) in antimicrobial assay. These results give evidence that it is essential to 
scrutinize these under explored marine microbes in search of new drugs which have great potential to be used 
in the pharmaceutical fields. 
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Actinomycetes have been the best 
source for novel drug's discovery. This is why 
these microbes are regarded as the most prized 
microbes in the pharmaceutical field, notable 
for its antibiotic production (Brun et al., 2000; 
Berdy, 2005, Atta et al., 2010). The enormous 
therapeutic potentials of actinomycetes are 
closely related to its abilities to produce 
secondary metabolites for its survival, in 
which most of it are rich in bioactive 
compounds (Lam, 2006; Kekuda et al., 2010; 
Naine et al., 2011). Natural products of 
actinomycetes are critically important for the 
development of new drugs. Therefore, it has 
caught the attention of many researchers to 
explore various environments in search for 
rare actinomycetes. 
Malaysia is a tropical country located 
in southeast Asia, one of the regions with the 
most extensive coastline in the world 
(Carpenter and Springer, 2005). Being 
surrounded by approximately 9,323 km of 
coastline, Malaysia has many beautiful 
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islands, in which most of them are important 
tourism spots due to their conserved 
environment. In particular, Sipadan Island at 
the southeast coast of Sabah, is well known 
for its diverse marine biodiversity due to its 
location at the heart of Indo-Pacific basin, 
which is the centre of one of the richest 
marine habitats in the world (Spadi, 2005). 
Great numbers of marine life are able to 
colonize this undisturbed environment, due to 
their adaptation to grow under extreme ocean 
conditions. It is interesting to note that the 
chemical constituents of metabolites produced 
by microorganisms vary greatly as the result 
of its extreme living environments, suggesting 
marine actinomycetes might produce different 
secondary metabolites compared to those of 
the same species at the less challenging 
environments. 
From our thorough investigations, it 
has come under the attention that marine 
actinomycetes have enormous therapeutic 
potential and could be pharmaceutically 
exploited as the resources of novel drug’s 
discoveries (Olano, 2009). 
The aim of this research was to 
investigate the antimicrobial and antioxidant 
properties of marine actinomycetes isolated 
from sponges collected closed to conserved 
sea area of Sipadan Island. In this study, the 
secondary metabolite’s extracts from 100 
strains of the marine actinomycetes were 
tested for its potential antimicrobial and 
antioxidant activities by using disc diffusion 
methods and 1, 1-diphenyl-2-picrylhydrazyl 
(DPPH) scavenging activity, respectively.  
Both activities have been selected for 
this study because of their great medicinal 
relevance. Bacterial infections are 
increasingly difficult to treat by using most of 
the currently available antibiotic agents due to 
the emergence of many antibiotic-resistance 
pathogens (Tanaka et al., 2006; Sengupta and 
Chattopadhyay, 2012). On the other hand, the 
increasing rate of chronic and degenerative 
diseases such as cancer, arthritis, autoimmune 
disorders, cardiovascular, acceleration of 
aging process and neurodegenerative diseases, 
in which caused by the accumulation of free 
radicals in the body (Pham-Huy et al., 2008) 
have urged the need for new antioxidant drugs 
from these underexplored marine 
actinomycetes. 
 
MATERIALS AND METHODS 
Methods 
Sample collection 
Marine sponges were collected around 
Semporna coastal area (4°06'52.92"N and 
118°38'04"E). This area is a conserved region 
that is located of a close distance from 
Sipadan Island (Figure 1). The samples were 
taken by scuba diving at depth between 10-15 
m. All samples were kept in a sterilized slip 
bag and stored in -40 °C freezer upon arrival 
at the laboratory.  
 
Actinomycetes isolation 
Approximately 3 cm of tissue from 
mesophyll part of sponge was excised and 
homogenised in 10 ml seawater using sterile 
mortar. Homogenate serially diluted and 
plated on starch casein agar (SCA) prepared 
by using seawater (nalidixic and 
cycloheximide supplemented). Plates of 
isolation media were incubated for 3 weeks in 
the incubator at 28 °C. The resulting colonies 
on HV agar were further sub-cultured on 
oatmeal (OA) agar with pH 7.2. 
 
Determination of actinomycetes by non-
staining KOH method 
A drop of 3% aqueous KOH was 
placed on a slide. Using a sterile loop, a 
visible amount of bacterial growth is 
transferred from the agar culture to the drop of 
KOH. The cells and KOH were mixed 
thoroughly on the slide, constantly stirring 
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over an area about 1.5 cm in diameter. If the 
bacterium-KOH suspension becomes 
markedly viscid or gels within 5 to 60 
seconds, the isolate is Gram negative. If no 
gelling is observed, the isolate is Gram 
positive. The best way to test the viscosity is 
to raise the loop about 1 cm from the slide. If 
an obvious stringiness is present, then the 
culture was gram negative. The actinomycetes 
can be identified by the sporulation on OA 
media and also non gelling formation on 
slides. 
 
Fermentation and extraction 
Productions of microbial secondary 
metabolites were from actinomycetes grown 
in 2% mannitol + 2% peptone + 1% glucose 
liquid medium at 28 °C for 5 days. The liquid 
medium was prepared in 100% seawater. The 
25 ml culture in conical flask (250 ml) was 
shaken at 220 rpm in shake-flask incubator. 
The secondary metabolites from 
actinomycetes were extracted by using equal 
volume of acetone to culture medium. 
 
Antioxidant test. 
Different concentration (100, 50, 25, 
12.5 and 6.25 µg/ml) for each sample were 
dissolved in water and taken in tubes 
separately. Ascorbic acid was also prepared in 
different concentrations (100, 50, 25, 12.5 and 
6.25 µg/ml ) and this was used as a reference 
standard. DPPH (1, 1, Diphenyl-2-Picryl 
hydrazyl) 0.002% was freshly prepared in 
ethanol. DPPH (2.7 ml) was added into each 
tube containing different concentrations of 
extracts (0.3 ml) and of standard solution (0.3 
ml). It was shaken vigorously with a vortex. 
They were then allowed to stand for 60 
minutes for room temperature in dark place. 
The control was prepared without any extracts 
(0.3 ml water added with 2.7 ml of 0.002% 
DPPH). Ethanol was used for base line 
corrections in absorbance (OD) of sample 
measured at 517 nm. The below formula was 
used to interpret the value of the sample. 
% DPPH Scavenging Activity = [(control O.D 
– sample O.D) / control O.D] x 100 
The antioxidant potential of each 
extract was expressed as IC50 value, 
indicating the minimal concentration to inhibit 
50% of the DPPH free radicals. 
 
Antimicrobial assay 
Antibacterial activities were assayed by 
using well diffusion method against the eight 
standard test organisms namely Bacillus 
cereus, Bacillus subtilis, Staphylococcus 
aureus, Streptococcus pyogenes, Escherichia 
coli, Klebsiella spp., Streptococcus 
pneumonia and Pseudomonas aeruginosa. 
The test organisms were grown in sterile 
nutrient broth at 37 oC for 12 hours and 200 µl 
of broth containing the test organism is added 
into 100 ml of priorly autoclaved nutrient 
agar. Sterile filter paper discs 6 mm in 
diameter were impregnated with 20 µl of each 
extract (30 mg/ml) which were prepared using 
the same solvents employed to dissolve the 
extracts, and then sterilized, and placed on the 
agar surface containing each test organism. 
Standard 6-mm discs containing 
chloramphenicol were used as positive 
controls. Negative controls were made using 
paper discs loaded with 20 µl of the solvents. 
The plates were incubated overnight at 37 °C 
for 18-24 hours. At the end of the incubation 
period antimicrobial activity was evaluated by 
measuring the diameter of inhibition zone.
 





Figure 1: Sabah sea area (Red circle shows the sampling area).
 
RESULTS 
This study describes the antimicrobial 
and antioxidant activities of marine 
actinomycetes from conserved sea area of 
Sipadan Island. The crude extracts of 
secondary metabolites from 100 strains of 
marine actinomycetes were tested for both 
assays in which only 22 and 31 strains showed 




The antioxidant activities of all the 
crude extracts were analyzed by using DPPH 
assay and only 22 strains showed antioxidant 
activities. The percentage of DPPH 
scavenging activities of all five different 
concentrations for each extracts were 
calculated and the IC50 values of the 
secondary metabolites from the 22 strains 
extracts were determined (Table 1). The IC50 
values of the 22 extracts ranged from 56 
µg/ml  to 99 µg/ml, in which the most 
remarkable value was exhibited by strain 
MSA07 with 56.3 µg/ml. It is impressive that 
the IC50 values of all the 22 active extracts 
are in the range of µg/ml, considering all are 
of their crude extracts. Though the working 
extracts are of crude and of low concentration, 
these extracts gave potent antioxidant 
properties when compared with ascorbic acid 
as the standard antioxidant. 
From all of the 22 extracts, the 
percentage of DPPH scavenging activities 
increased as the concentration of extracts 
increased (Figure 2, 3, 4 and 5). Strong 
antioxidant activities were observed on the 
crude extracts of strain MSA07 and MSA82 
with 67.81% and 71.30% of scavenging 
activities at 100 µg/ml, respectively.  
 
Antimicrobial activity 
The results of the antimicrobial 
activities are shown in Table 2. From 100 
strains tested, 31 strains showed antimicrobial 
activities against the test pathogens. The most 
prominent finding in this assay was the 
abilities of the marine actinomycetes strains to 
inhibit more than just one pathogen. Out of 31 
bioactive strains, 24 strains exhibited 
antimicrobial activities against at least two 
pathogens, in which four strains such as 
MSA18, MSA23, MSA26 and MSA62 
successfully inhibited up to five strains of 
pathogens. The data also showed that the 
numbers of strains that were able to inhibit 
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gram positive bacteria (Bacillus cereus, 
Bacillus subtilis, Staphylococcus aureus, 
Streptococcus pyogenesand Streptococcus 
pneumonia) were higher compared to the 
gram negative bacteria (Escherichia coli, 
Klebsiella spp. and Pseudomonas 
aeruginosa). Staphylococcus aureus was the 
most susceptible pathogen, in which 16 
extracts of marine actinomycetes strains were 
able to inhibit this pathogen. On the other 
hand, Escherichia coli appeared to be the least 
susceptible pathogens with only eight extracts 

































Figure 2: The DPPH scavenging activity of strains MSA01, MSA03, MSA07, MSA18, MSA22 and 
MSA24. All samples with different concentration are compared with ascorbic acid as antioxidant which shows 95.8% of 

































Figure 3: The DPPH scavenging activity of strains MSA27, MSA29, MSA31, MSA42 and MSA45. 
All samples with different concentration are compared with ascorbic acid as antioxidant which showed 95.8% of DPPH 
scavenging activity at concentration of 100µg/ml. 
 







































Figure 4: The DPPH scavenging activity of strains MSA47, MSA48, MSA50, MSA57 and MSA74. 
All samples with different concentration are compared with ascorbic acid as antioxidant which showed 95.8% of DPPH 






































Figure 5: The DPPH scavenging activity of strains MSA76, MSA79, MSA82, MSA84 and MSA92. 
All samples with different concentration are compared with ascorbic acid as antioxidant which showed 95.8% of DPPH 
scavenging activity at concentration of 100µg/ml. 
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Table 1: IC50 values of antioxidant activity. 
 























IC50  values in µg/ml. MSA = Marine Sponge Actinomycetes. 
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Table 2: Antimicrobial activity of marine actinomycetes. 
 
Strains Antimicrobial assay (mm) 
STAPH A STREP A KLEB B.C B.S S.P E.C P.A 
MSA01 9±0.6 - - 10±0.0 - - - - 
MSA03 12±0.0- 11±0.0 - - - - - - 
MSA07 9±0.0 - 10±0.0 - 8±0.0 - - 12±0.0 
MSA09 8±0.0 - - 9±0.0 12.3±0.6 - - - 
MSA15 - - - 12.3±0.6 -10±0.0 - - 10±0.0 
MSA18 8±0.0 8±0.0 - 8±0.0 8±0.0 - - 8+0.0 
MSA22 10±0.0 19±0.0 - - 9±0.0 - - - 
MSA23 9±0.0 11±0.0- 8±0.0 8±0.0 10±0.0 - - - 
MSA26 10±0.0 10±0.0 - 10±0.0 10±0.0 10±0.0 - - 
MSA34 8±0.0 9±0.0 - - - - - - 
MSA36 - - - 10.3±0.6 11±0.0 8+0.0 9±0.0 - 
MSA37 9.3±0.6 - 9±0.0 - - - 10±0.0 - 
MSA41 - - 11±0.0 - - 9±0.0 8±0.0 - 
MSA44 9±0.0 9±0.0 - - - - - - 
MSA46 10±0.0 9±0.0 11±0.0 - - - - - 
MSA49 - - - 14±0.0 10±0.0 10±0.0 - - 
MSA52 - - - - - - 11±0.0 13±0.0 
MSA57 - - - - - 10±0.0 - - 
MSA60 10±0.0 10±0.0 - - - 13±0.0 - - 
MSA62 9±0.0 10±0.0 - 14±0.0 10±0.0 10±0.0 - - 
MSA65      11±0.0 13±0.0 8±0.0 
MSA68   11±0.0      
MSA69 9±0.0 10±0.0 11±0.0      
MSA73 8±0.0 11±0.0  10±0.0 13±0.0    
MSA77   9±0.0   12±0.0  15±0.0 
MSA79 13±0.0 13±0.0 13±0.0     14±0.0 
MSA82  10±0.0  11±0.0 14±0.0    
MSA84   13±0.0    10±0.0 12±0.0 
MSA95 12±0.0 13±0.0 12±0.0     8±0.0 
MSA98    13±0.0   9±0.0 9±0.0 
MSA99 12±0.0 15±0.0     8±0.0  




The data from this research confirmed 
the therapeutic potential  of marine 
actinomycetes from the conserved sea area of 
Sipadan Island as they possess strong 
antioxidant and antimicrobial activities in 
their crude secondary metabolites. This study 
has demonstrated for the very first time that 
the marine actinomycetes from this pristine 
sea area do possess great pharmaceutical 
value. 
Other marine actinomycetes isolated 
from other region of the world also exhibited 
antioxidant activities. A compound known as 
Diazepinomidin have been isolated from 
marine sponges-associated strains 
Micromonospora sp. RV115 and it exhibited 
significant antioxidant and protective capacity 
from genomic damage induced by the reactive 
oxygen species hydrogen peroxide in human 
kidney (HK-2) and human promyelocytic 
(HL-60) cell lines (Abdelmohsen et al., 2012). 
In addition, the secondary metabolites of 
Streptomyces sp. VITTK3 from marine soil 
sample collected at the Bay of Bengal, India 
also has the antioxidant activities on DPPH 
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assay (Kannabiran et al., 2010). The data in 
this study showed that the marine 
actinomycetes isolated from Sipadan Island 
have great antioxidant potential as the IC50 
values of all the active crude extracts were 
only in the low concentration range of µg/ml.  
The ability of marine actinomycetes 
strains isolated from Sipadan Island to inhibit 
the growth of multiple pathogens only by 
using 30 mg/ml crude extracts may provide 
the alternative for the development of new 
antimicrobial drugs. Recently, marine 
actinomycetes have become an important 
source for the development of new 
antimicrobial drugs worldwide, in which 
novel antimicrobial compounds such as 
Abyssomicin C and Lactonamycin have been 
discovered from these marine microbes 
(Matsumoto et al, 1999; Bister et al., 2004; 
Lam, 2006). Despite this potential, this study 
is the first that revealed the antimicrobial 
properties of marine actinomycetes from the 
conserved sea area of Sipadan Island.The 
finding in this study is crucial for the effort to 
cure bacterial infection in human population, 
given that the current treatments of bacterial 
infections are really difficult and challenging 
due to the ability of bacteria to develop 
resistance towards the currently available 
antibiotic drugs (Tanaka et al., 2006; Tenover, 
2006). 
This study demonstrated that there are a 
total of 10 strains that showed activity on both 
antioxidant and antimicrobial assays. They are 
MSA01, MSA03, MSA07 MSA18, MSA22, 
MSA34, MSA79, MSA79, MSA82 and 
MSA89. This indicated that these marine 
actinomycetes can be a major source for new 
antioxidant and antimicrobial drugs by its 
production of secondary metabolites. The 
ocean has various levels of pressure, salinity 
and temperature depending on time and 
season (Olano et al., 2009).Therefore, marine 
actinomycetes from the sea area of Sipadan 
Island, which is one of the world’s most 
primitive ocean, may exhibit a huge potential 
of many unknown pharmaceutical 
applications that are yet to be discovered since 
they have the ability to produce new chemical 
entities with diverse pharmacological 
activities (Lam, 2006). 
 
Conclusion 
The successful isolation of marine 
sponges-associated actinomycetes from 
Sipadan Island proved that this conserved area 
does have enormous marine actinomycetes 
diversity that yet to be discovered. The novel 
discovery of remarkable antioxidant and 
antimicrobial activities showed that it is 
importance to exploit the actinomycetes from 
Sipadan Island. The antioxidant and 
antimicrobial activities of the active strains 
can be further enhanced through the 
purification process in the future work, and 
these secondary metabolites can be used as 
natural antioxidant and antimicrobial drugs to 
replace the artificial drugs that are currently 
available for the same treatment. 
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